(2 years, 10 months ago)
Commons ChamberMy hon. Friend is absolutely right, and he does well to highlight the pre-payment certificate. If people go for a 12-month certificate, which is about £2 a week, for two items they can save £116.30 and for three items, £228.50, so it is well worth the investment.
Following consultation last September, we announced that we would legislate to fortify non-wholemeal wheat flour with folic acid. We are working at pace to move this policy forward, and we have already engaged with industry as part of a cross-Government review of bread and flour regulations. All four nations are now working closely together to develop the draft legislation and impact assessment for future consultation.
I thank the Minister for her answer. As she knows, the Scientific Advisory Committee on Nutrition has recommended mandatory folic acid fortification of flour. The UK Government launched a public consultation that closed in 2019. In September last year, the UK Government announced that folic acid will be added to non-wholemeal wheat flour across the UK to help to prevent life-threatening spinal conditions in babies. Therefore, can the Minister update the House on the UK Government’s timeline to implement the decision in a wee bit more detail, please?
I thank the hon. Gentleman for raising this important issue, because fortifying non-wholemeal wheat flour with folic acid will help to prevent hundreds of neural tube defects in foetuses every year. I regret that I cannot commit to a specific timetable, but we need to consult on the draft legislation and will look to give industry appropriate notice. All four nations are working together on the timetable and hope to deliver this important policy as soon as possible.
(3 years ago)
Commons ChamberI pay tribute to my hon. Friend for her work in this role and also to all unpaid carers. There are 5.4 million unpaid carers in England and they do a fantastic job. In the forthcoming Bill that we are co-producing with unpaid carers, we will make sure that we continue to make progress in this area. I look forward to sharing that with her before the end of this year.
Carers UK recently called for an additional payment across the UK for unpaid carers after its survey found that more than one in five unpaid carers are worried that they may not cope financially over the next 12 months. In Scotland we already have a carer’s allowance supplement, and the Scottish Government will once again make a double payment this December, recognising the impact that the pandemic has had on our carers. Will the Minister now urge her colleagues in the Department for Work and Pensions to make a commitment to match the Scottish Government’s offer?
(3 years, 9 months ago)
Commons ChamberYes. We are absolutely all on the same side on this issue. To be totally clear for the hon. Lady, and all those listening, the Prime Minister set out that we would offer the vaccine to all residents of care homes by the end of January and to all staff by 15 February, and we achieved that. The challenge is uptake. Rather than having a political ding-dong about it, what we all need to do is get out the positive messages about the vaccination programme. I am delighted that the Minister for Care and the Minister for Covid Vaccine Deployment have both been working incredibly hard on this issue, and we published an uptake plan last weekend. I am sure the hon. Lady will want to join the efforts to try to encourage everybody to get the jab.
We are committed to supporting all NHS dental services through the pandemic. NHS practices receive full funding for the first three quarters of the year, minus agreed deductions in England, and NHS dental contractors will continue to be supported while they meet reduced activity targets. NHS England and Public Health England continue to communicate regular updates, enabling practitioners to prioritise urgent care and reduce waiting times in what are challenging circumstances.
The British Dental Association has raised concerns that punitive financial penalties for not meeting the Government’s unrealistic activity targets are pushing NHS dentists in England to prioritise quick check-ups rather than catching up on the backlog of more time-consuming symptomatic cases. Will the Minister consider a more realistic approach to service recovery and commit to reforming the dental contract in England so as to promote preventive dental care in future?
As anybody will know, I have been heavily engaged with the dental profession over recent months, because I agree that a preventive approach to dentistry is certainly one that we need to be moving towards. The activity target is expected to increase availability for patients, who are the important part of the equation. It is important that we support the profession but enable patients to have access and reduce waiting times and backlogs. The target is based on careful modelling—on data—and takes into account guidance on infection prevention and control and social distancing measures. We recognise that there may be exceptional circumstances, which is why there are exceptions to the target level. NHS commissioners have the discretion to deal with exceptions and support dental practices. I have a meeting with everyone again on Thursday.
(5 years, 4 months ago)
Commons ChamberOur highest priority is for patients to continue to have access to medicines and medical products in all Brexit scenarios. As a responsible Government, we will minimise any disruption in our exit, deal or no deal.
On 26 June, we set out our approach to ensuring continuity of supply. I discussed this last week with the head of the NHS, and Professor Keith Willett wrote to all NHS trusts yesterday to advise on no-deal planning.
Concerned breast cancer charities have asked me and others to ask the Secretary of State if he will confirm to us, and to them, whether he is leasing enough ferry capacity to ship in medicines in the very likely event of shortages in the UK when we leave the EU.
Yes, we secured the requirements ahead of a potential exit on 29 March, and we are doing the necessary work to ensure that capacity is available, whatever the Brexit scenario, on 31 October.
(5 years, 6 months ago)
Commons ChamberI wish to extend my thanks to the right hon. Member for Hemel Hempstead (Sir Mike Penning) and the hon. Member for Gower (Tonia Antoniazzi) for securing this debate here today.
Several speakers have been quick to explain that this debate is about medical cannabis and not cannabis for recreational use, and, within the context of this debate, that is quite correct. The fact that we feel the need to explain that is a strong indication that there is, in the wider audience, a great deal of mistrust born through ignorance of what cannabis actually is. We even start getting confused when we try to differentiate between cannabis and hemp. What we have here is a mess of our own making.
This is about a plant that can be grown in the UK and, indeed, is already grown in the UK but under licence from the Home Office—more about that later. It is a plant that is good for the soil in which it grows; a plant of which almost every single part can be utilised to make bio-degradable plastics, bio-degradable cloth and, as we know, medicines; and a plant that has been cultivated for thousands of years in various forms. Why do we have an issue with it? Why has cannabis been demonised? When we mention the word cannabis, why for the majority of people does it conjure up the image of somebody sparking up a joint, a spliff, a jay, a doobie, or a roach? It is because, in the Misuse of Drugs Act 1971, this place got it horribly wrong. It fell in with the prohibitionist mantra from the USA and it made a range of drugs illegal.
Before then, we controlled their use; we tolerated that use socially; and we prescribed them as required. It was actually called the “British system”, and it worked. No criminal gangs controlled the production and distribution. There was no escalation in violence to protect the marketplace, no county lines and a lot less corruption. But with that one incredibly clumsy Act, we demonised the entire plant.
If we were talking about medical hemp today, a range of folk would be more open to the discussion, but because of one cannabinoid in the plant—tetrahydrocannabinol or THC—we have ignored the other 100-plus cannabinoids. We remain ignorant of the benefits they can bring and of how they interact with the endocannabinoid system that each and every one of us has in our own bodies.
The lack of medical research in the UK has led to an entirely unsuitable situation, and my frustration is that we seem to be in no hurry to clear it up. Why are we not moving heaven and earth to license products that are used widely in other countries? Across the UK today, people are suffering needlessly. The medicines exist and are being prescribed and used elsewhere, but the UK Government’s attitude is, “Nobody knows better than us.” We now find ourselves in a position where we are being forced to fight this issue one case at a time.
We brought Alfie Dingley to No. 10 to meet the Prime Minister. That seemed to make a difference. Billy Caldwell’s mum brought the matter to a head by attempting to bring the product into the country. That moved things on, too. And in their situation, would any of us not do the same? Would we not do whatever it took to gain access to medicine for our children? We cannot keep on fighting this on a case-by-case basis. It is cruel and heartless, and there are simply too many kids out there who could benefit now. I apologise to the many people who suffer with arthritis, multiple sclerosis and cancer, because we do not shout about them as much, and they also need to be listened to. The sad fact is that this Government have shown that it takes heart-breaking cases of kids with epilepsy to bring them to the table.
Would my hon. Friend confirm my understanding that, for the 10,000 people with MS who could benefit from cannabis for medical use, nothing has changed since 1 November 2018, when the Government made it legal for specialist doctors to prescribe cannabis-based medical products? Am I correct in thinking that that is true?
My hon. Friend is absolutely correct. I have a briefing from the MS Society that illustrates his point. It says that, since Thursday 1 November 2018:
“Nobody with MS has so far benefitted from the change in the law, and access to cannabis-based medicinal products remains very limited. This includes access to Sativex”.
Sativex is a licensed product. Of course, people can get it privately if they can spare £500 a month.
As I have said, the system is cruel and heartless. Let us look at one example of how stupid our current laws are and how damaging they are to the patients we are supposed to be helping. If a child suffers from certain forms of epilepsy, there is good evidence that a cannabis-based medicine called Bedrolite may be of great help. Any parent or guardian in that situation would want to access Bedrolite. I know of one child who was having 16 seizures a day and is now on Bedrolite. As of today, that child has been free of seizures for 50 days. Can we begin to imagine how great that is for the child and for his surrounding family and friends? But his supply is running out and his mother said to me yesterday, “I can’t let my boy get sick again.” What has she got to do to keep her boy well?
The good news is that people in the UK can get Bedrolite—if they are rich, if they fundraise, or if they go to a private clinic, pay for a prescription and then pay £560 per bottle. For one patient I know, that equates to £28,000 a year. And that is not the most expensive case I know of—not by a long way. I know of cases where it would cost people twice that much to medicate their children. If people are prepared to break the law to provide medicine for their child, they can travel to the Netherlands and purchase Bedrolite for £167 a bottle, reducing the annual cost to £8,100 a year, plus travel and accommodation costs, but those people risk being arrested and separated from the child they are trying to help.
I know of a wee boy in Scotland whose mum has brought back oils illegally from the Netherlands. He recently went through a bad spell of cluster seizures. Normally, he would be in hospital, unconscious, and unable to walk, eat, speak or swallow. This time, he has remained at home and has not needed any rescue medication. His mother should not have to pay thousands of pounds a month and break the law trying to help her sick child. It is no wonder that the scammers have moved into this marketplace. As a parent wrote to me yesterday to explain,
“The vultures are praying on very vulnerable desperate families and selling fake or non filtered oils which is unsupported and also very dangerous”.
This highlights another problem. When we sit back and do nothing, scammers and criminals will move in. People will say, “I’m buying a product that is cannabis, but it’s not doing me any good.” Then the Government will take another step back and say, “Well, the evidence simply is not there.”
People’s last option is to do what the Government have said they should do. To access medical cannabis, someone must have tried medical cannabis and experienced benefits, but, as I have pointed out, that involves either a lot of money or breaking the law. That is what the Government are asking parents to do. A person must have exhausted all other drugs, despite knowing they do not work and have many dangerous side effects; we are asking people to endure side effects and disappointment to justify their request. Once they have done that, they find that their GP cannot prescribe under the current system and that specialists are reluctant to do so because they are going out on a limb and fear reprisals from the medical community.
We have a situation where the UK Government say, “We have a system,” and absolve themselves of their responsibility and duty of care to the citizens of the United Kingdom. I was going to ask the Minister explain why we cannot treat any cannabis-based medical products as schedule 2 drugs under the statutory instrument where that product has been prescribed by a medical practitioner in another jurisdiction, but of course we have a Health Minister in front of us today, not a Home Office Minister. Yet again, this problem falls between two stools. The Home Office or the Department of Health and Social Care—who will take responsibility for this issue and move it forward?
While we delay, the privatised UK cannabis business grows and the privatised pharmaceutical companies are controlling the available products with an iron fist. It looks as though we are restricting the provision of medical cannabis while we evaluate a marketplace and develop products with the intention of making a lot of money out of it, but the Government would not be that cruel, would they? Not deliberately! The Government do not have a vested interest in the pharmaceutical industry, do they? They are not granting licences to their pals to grow cannabis or encouraging family members to invest in pharmaceutical companies with a vested interest, are they? Surely not. But of course, we know that they absolutely are. That is the backdrop to the photo opportunities and the sympathetic words of staged understanding from Ministers. Unless someone has a child living in these circumstances, they cannot possibly understand the need, the frustration and the anger. As politicians, we are elected to listen to the people. The parents and guardians of these young men and women are screaming at us, “Give us access to affordable, legal medication for our children, and do it now.”
(5 years, 6 months ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
It is always a pleasure to serve under your chairmanship, Ms Ryan. I, too, congratulate the hon. Member for Newcastle upon Tyne North (Catherine McKinnell) on securing this debate today following national Deaf Awareness Week. Her initiatives in Newcastle are very worthy; she clearly cares passionately. I add my congratulations to the thought given in having BSL interpreters and signers here today. That was really good thinking. As always, it is a pleasure to follow the hon. Member for Strangford (Jim Shannon) and other Members who have spoken today.
Every day, people with hearing loss get on with work and family life while dealing with all the challenges that that brings. It is difficult to imagine what it is like to cope with a job using public transport, as well as coping with shopping and meeting your child’s teacher, when basic communication, which the rest of us take for granted, does not come easily. Almost 9 million citizens in the UK, including 50,000 children and 758,000 people in Scotland, have some degree of hearing loss, as have I. At least 24,000 use British Sign Language as their main form of communication. They are a large and important part of our community, and they need us to be more aware.
Access to NHS services is an important improvement that we can make to the lives of those in our deaf community. To support people who use British Sign Language, as mentioned earlier, NHS Scotland has created information in BSL for a range of health topics, including accessing NHS services in Scotland.
Scotland was the first country in the UK to legislate for BSL to achieve legal status. The British Sign Language (Scotland) Act 2015, passed unanimously by the Scottish Parliament, promotes the use of British Sign Language and made provision for the preparation and publication of the British Sign Language national plan for Scotland, which we now have. The BSL national plan sets out 70 actions that Ministers will take to improve the lives of people who use sign language, backed by £1.3 million of public funding.
Under the plan, BSL users will have access to the information and services that they need to live active, healthy lives and to make informed choices at every stage of their lives. The national plan’s health, mental health and wellbeing actions include, among other things, publishing a schedule for making all screening and immunisation information accessible in BSL; increasing the availability of accurate and relevant health and social care information in BSL; developing a learning resource for health and social care staff to raise awareness of sign language and deaf culture; and working with partners to deliver and evaluate two training programmes aimed at supporting BSL English interpreters to work within the health sector, with a view to informing a longer-term approach.
NHS Greater Glasgow and Clyde has appointed a health improvement practitioner to support mental health in the deaf community, which will help raise mental health awareness and empower that community, allowing them better access to services. In the wider community within my own Falkirk constituency, I have surgeries every month at a wonderful place called the Forth Valley Sensory Centre, which is run by volunteers. I can recommend its coffee and square sausage. People with hearing loss are welcome to come along. Everyone is welcome, by the way, if they like square sausage.
The Minister is not familiar with the concept of square sausage.
Many people are not familiar with the concept of square sausage. I tried to introduce it some time ago when I first came down here; it was refused by the catering staff, but I shall redouble my efforts.
The centre is a place where people with hearing loss or visual difficulties can access quality services, advice and equipment that helps them to be as independent as possible. Practical support is there for the deaf community at all stages in their lives. In fact, my mother-in-law, Mrs Chalmers, and my own mother, Rosa, made use of the services in the not-too-distant past. Young people looking for work can access advice on job seeking and training. It is also a thriving social hub, holding a range activities and giving folk a chance to chat, try new skills and have fun. It was the first of its kind in the UK and has proven to be an absolutely invaluable resource to the community.
As with all language skills, it is good to teach communication to the young. We see successful examples in some children's television programmes, using a system of signs and symbols called Makaton. It is picked up by all young viewers, not just the deaf community. The more who know some of the skills, the better. It helps us talk to each other at the earliest stages.
I want to draw attention to the inspiring “I’d like to teach the world to sign”, an initiative known as Hands of the World, co-ordinated by the remarkable Sharon Tonner-Saunders of the University of Dundee. She brings music and sign language together across the globe. Some 40 countries are participating. It is a great example of horizontal communication integration, and I ask everyone to Google it and have a look.
The Scottish Government have a plan for primary schools called the 1+2 language plan, which requires every child of primary school age to have experience of their native language, whatever it may be, and of two additional languages—they could be French, Mandarin or British Sign Language. The Scottish Qualifications Authority qualification in BSL is being developed and SCQF levels 5 and 6 will be available from autumn 2019. The UK Government have not yet committed to introducing a GCSE BSL qualification. Rather, they will consider introducing one before 2022, but we hope that action will be taken sooner.
We want to make Scotland the best place in the world for BSL users to live, work and visit. A start has been made, but the efforts must continue. I hope the same thing happens here in Westminster, so let us keep talking—and, of course, signing.
(5 years, 6 months ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
The hon. Lady is correct. I pay tribute to her and to the hon. Member for Swansea East (Carolyn Harris) for setting up the new all-party parliamentary group on beauty, wellbeing and aesthetics, along with me. I look forward to her interventions at meetings of that all-party group; I know she has a great deal of knowledge of this area. I agree that we do not want to stifle the beauty industry—we want it to grow and be successful—but we all want to protect our constituents.
I congratulate the hon. Gentleman on setting up the APPG. I am the chair of the APPG on the hair industry and I am keenly interested in this development. A possible solution to the problem has been put forward by the British Association of Beauty Therapy and Cosmetology. It appreciates the concerns about mandatory registration, but thinks that a regulatory framework, led by the Government, would be difficult to implement and that the voluntary self-regulatory framework is not working either. BABTAC believes that the time has come for the Government to institute a mandatory regulatory framework that would be self-governing and would include BABTAC and the Royal College of Surgeons. Does the hon. Gentleman agree with that?
I agree. The hon. Gentleman has been doing sterling work on behalf of his constituents in related matters with his sister-APPG, and we wish him every success with that. He is right that we have to look at the issue in the round and include professionals who are experts in the field, who contribute to our economy and who themselves want a properly regulated beauty industry.
I agree entirely, and I encourage the hon. Gentleman to join both the excellent APPG of the hon. Member for Falkirk (John Mc Nally), and that set up by the hon. Members for Swansea East and for Bradford South (Judith Cummins) and me. They are complementary APPGs and we would welcome the hon. Gentleman’s interest and expertise.
I mentioned a moment ago that this debate should not centre on the conversation about medics or non-medics carrying out these procedures; I believe it is fine for properly qualified and regulated beauticians to be able to offer them. I also highlight the fact that people who receive botched fillers often end up having to go to our national health service to pick up the pieces, as my hon. Friend the Member for Ribble Valley mentioned a moment ago, so that ultimately the taxpayer has to foot the bill.
As the Keogh review concluded:
“Dermal fillers are a particular cause for concern as anyone can set themselves up as a practitioner, with no requirement for knowledge, training or previous experience.”
In February 2014, it was made illegal to offer dermal fillers without training, but the training has not been clearly defined, and some of those who may be qualified to give lip fillers may not have the necessary training to be able to dissolve them or identify when something has gone wrong. We have met or heard from beauticians who would argue that they are properly trained or qualified, but in some instances they can be trained or qualified only for one part of the procedure, and not necessarily for when things go wrong. Surely, anyone carrying out these procedures should be able to identify when things have gone wrong and remedy them immediately.
The British Association of Aesthetic Plastic Surgeons would like to see the development of clinical guidelines on the use of dermal fillers. The Royal College of Surgeons has also expressed that it would like to see dermal fillers classified as a prescription-only medicine. Serious complications of cosmetic procedures can include infection, nerve damage, blindness, blood clots and scarring. That links to what the Government have helpfully announced today, as the campaign will help to inform consumers of those risks. They are also recommending that consumers go to a regulated healthcare professional.
The medical director at NHS England, Professor Stephen Powis, has said that professionals who provide procedures such as fillers should be encouraged to join the new Joint Council for Cosmetic Practitioners. That is very sensible, as it has been set up to assist members of the public, although it is not obligatory. We also face the surrounding issue of body dysmorphia and mental health. Professor Powis has also argued that practitioners should be officially registered and trained to identify people who may be suffering from a body image or other mental health-related issue.
Social media is a powerful tool for young people to look at and to share their experiences. Platforms such as Instagram and Facebook are often used as a principal source of information when people are researching fillers and Botox. I argue that that should not be the case: education on those matters should ideally be face to face when someone is having the procedures, with a trained and regulated practitioner.
Rather surprisingly, there is no age restriction on cosmetic procedures, and I argue that we should have one. The Nuffield Council on Bioethics recommended that children under 18 should not be able to have these procedures unless there was an overriding medical reason for them to do so. As a comparison, the law as it stands in England is that if someone wants to use a sunbed, they must be over 18. I mentioned unregulated vets earlier; we would not consider taking a valued pet to an unregulated vet to have an injection, so why would anyone let, for example, their 16-year-old daughter have someone unregulated inject something potentially poisonous into her face? I invite the Government to consider age restrictions.
The other point I will make is about the content of many dermal fillers. There is a total lack of regulation on the content—that is, the chemical ingredients. According to the British College of Aesthetic Medicine, there are more than 60 dermal fillers available in the UK market alone. It should shock us that we often do not know the content of those fillers and what poisons they may well contain that might have a negative impact on someone’s body.
I believe that urgent regulation is required to protect consumers—our constituents. The steps that the Minister and her Department have taken today are very welcome indeed, but we must do more. I look forward to the Minister’s comments, because I am confident that she is looking into this.
People who put their life savings into investing in their businesses need reassurance that their investment is protected and not undermined by poorly-trained practitioners, because we all make assumptions—seemingly unfounded ones—that those businesses all operate legally and above board. I must bring to the attention of hon. Members the fact that I have met with the insurance companies, which are deeply concerned about the lack of regulation in this particular business. I wonder whether the Minister will comment on how businesses could be better insured and how we could make this a viable business that would not be undermined by other people.
The hon. Gentleman makes an important point, because this goes to the heart of what professional indemnity insurance is. One of the principal points of regulation is that a consumer knows that, if the professional is negligent, as people often are—people make mistakes—they will not be suing a man or woman of straw; that professional will have professional indemnity insurance behind them. That is the right form of protection in our society, in addition to qualifications and training.
I am pleased to champion this issue, along with the hon. Members present. I once again encourage the Government to continue doing the right thing, and to lead us to a situation in which we have a properly functioning and regulated beauty industry.
I accept that invitation most gratefully, and I look forward to hearing the conclusions. The time is right for us to take action on this, and I am grateful for the support of Members from across the House in wanting to do that and to do the right thing, with the intention of protecting consumers, which is obviously central to us, but also ensuring a system of regulation that is proportionate for the industry. We need to make sure that we balance both of those.
We have not really given the industry enough attention, given the speed with which it has grown. We increasingly see examples of consumers receiving poor treatment; my hon. Friend the Member for South Leicestershire referred to his constituent, to whom I am grateful for sharing her story. We need to make everyone much more aware of the risk because, as he says, people think it is just like having a haircut; it is becoming extremely normal to have what are poisons injected into the face. We need to make sure that everyone is aware of the risk before they undertake such a procedure, so that they can make an informed judgment.
I am not taking exception to the idea of it being just like having a haircut, but I have been involved in the business of hair salons for more than 50 years and have run salons, and it is not just like having a haircut. There is a similarity in terms of the investment put into any business, which is long term in some cases. When somebody comes along who has not properly trained and has little knowledge, there will be consequences of what they practise. In my all-party parliamentary group’s inquiries, we have come across modern-day slavery, trafficking, money laundering and all sorts of things, which just builds the case for a mandatory regulatory framework.
The hon. Gentleman makes a good point, because when we talk about these examples, there is a danger that people can apply that prejudice to the entire industry. It is in the interests of everyone involved in this industry to welcome regulation, not least to celebrate the professionalism of what they do. There are some very reputable practitioners out there who are not actually in the medical industry. For example, semi-permanent make-up—a surgical procedure that does not involve any invasion—clearly does not require as strident regulation as what we are talking about with injectables, but it is the same industry, and we need to ensure an adequate registration system.
(5 years, 8 months ago)
Commons ChamberRegardless of my party’s opposition, in principle and in entirety, to the UK’s withdrawal from the EU, I recognise that it is crucial that statutory instruments are enacted to preserve a framework around the status quo. That framework will be essential to our future trading relationships with the EU and the rest of the world.
Scotland’s booming food and drinks industrysupports 119,000 jobs and exports £6 billion-worth of produce, 40% of which goes to our European neighbours. Consumers and farmers remain sceptical about the need for GM crops, and allowing GM crops in Scotland would threaten our country’s international reputation as a clean, green food and drink producer.
The Scottish Government remain totally committed to opting out of allowing the cultivation of GM crops, thereby giving policy certainty to producers and investors, in stark contrast to the uncertainty and paralysis of the UK Government. Public concern about hormone-tainted meat and chlorine-washed chicken demonstrates how critical food standards will be post-Brexit, both at home and abroad. In my hometown of Denny, which is in my Falkirk constituency, we have a business that exports broiler chickens to Europe and the world, and everywhere it sends those chickens it is recognised as the best in the world. My party intends to ensure that this valuable industry continues to flourish, and we will oppose any attempt to lower the food standards on which its future depends.
The UK imports around £2 billion-worth of animal feed, much of it from the EU or through EU ports. Maintaining high quality standards and as free a flow of trade in such commodities as possible is vital to Scotland’s rural communities, particularly those in less favoured areas. Just yesterday, the Scottish non-governmental organisation Scottish Rural Action, a great voice for Scottish rural communities, released a hard-hitting report documenting the widespread anger and frustration felt in Scotland’s rural communities, and reporting fears of 21st-century clearances in Brexit’s wake. These communities need assurances and protection.
The health and welfare of the UK’s 54 million pets also hang in the balance. The Pet Food Manufacturers Association has placed feed safety standards, together with animal health and welfare, at the top of the list of priorities in its Brexit manifesto. Some 80% of its members export to our European neighbours, and half of them import raw materials or finished goods from the EU.
These statutory instruments do not change the legal status quo, and therefore they safeguard confidence in the maintenance of quality standards. In turn, they ensure confidence in our food and drink industry and in the animal feed sector, and that confidence should be maintained. My party intends to ensure that these valuable industries continue to flourish, and we will oppose any attempt to lower these standards.
(7 years, 8 months ago)
Commons ChamberCough-assist machines are one of a variety of respiratory treatments that may be appropriate for sufferers of conditions such as motor neurone disease or muscular dystrophy. In the end, it is a matter of clinical judgment.
There are good examples of best practice cough-assist commissioning policies for muscle-wasting conditions that can be followed by health boards and CCGs. Given the hard work being done to extend the lives of those who suffer from muscular dystrophies, what support and assistance can the Department provide to Muscular Dystrophy UK to ensure that such policy is more widely adopted?
It is not for the Government to direct clinicians regarding the efficacy of particular treatments; it is for clinicians to decide, based on guidance from the National Institute for Health and Care Excellence and others. In developing its recent motor neurone disease guidance, NICE found that the evidence base for the routine use of cough-assist machines was weak. However, the matter is kept under review, so that may change as and if new data emerge.
(7 years, 9 months ago)
Commons ChamberThe current stroke strategy was produced in 2007 and our priority is to implement it fully. Frankly, in my time as a Minister, I would prefer to have detailed implementation plans and not more strategies. My hon. Friend refers to the great differences in performance across the country, in particular in access to speech and language therapy, and we need to achieve better on that.